These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 37124884)

  • 21. COVID-19-associated diarrhea.
    Megyeri K; Dernovics Á; Al-Luhaibi ZII; Rosztóczy A
    World J Gastroenterol; 2021 Jun; 27(23):3208-3222. PubMed ID: 34163106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastrointestinal manifestations of coronavirus disease 2019.
    Joshi T; Ahmed A; Cholankeril G
    Curr Opin Infect Dis; 2021 Oct; 34(5):471-476. PubMed ID: 34524198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastrointestinal sequalae months after severe acute respiratory syndrome corona virus 2 infection: a prospective, observational study.
    Liptak P; Duricek M; Rosolanka R; Ziacikova I; Kocan I; Uhrik P; Grendar M; Hrnciarova M; Bucova P; Galo D; Banovcin P
    Eur J Gastroenterol Hepatol; 2022 Sep; 34(9):925-932. PubMed ID: 35913778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastrointestinal manifestations and SARS-CoV-2 infection.
    Pizuorno A; Brim H; Ashktorab H
    Curr Opin Pharmacol; 2021 Dec; 61():114-119. PubMed ID: 34688995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The gut microbiome: a missing link in understanding the gastrointestinal manifestations of COVID-19?
    Brooks EF; Bhatt AS
    Cold Spring Harb Mol Case Stud; 2021 Apr; 7(2):. PubMed ID: 33593727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism and potential treatments for gastrointestinal dysfunction in patients with COVID-19.
    Yao Y; Liu ZJ; Zhang YK; Sun HJ
    World J Gastroenterol; 2022 Dec; 28(48):6811-6826. PubMed ID: 36632313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 and diarrhea: putative mechanisms and management.
    Juthi RT; Sazed SA; Sarmin M; Haque R; Alam MS
    Int J Infect Dis; 2023 Jan; 126():125-131. PubMed ID: 36403817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID 19 in Children: Gastrointestinal, Hepatobiliary and Pancreatic Manifestation.
    Fathema K; Hassan MN; Mazumder MW; Benzamin M; Ahmed M; Islam MR; Haque N; Sutradhar PK; Rahman AR; Rukunuzzaman M
    Mymensingh Med J; 2021 Apr; 30(2):570-579. PubMed ID: 33830145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19.
    Zhang H; Shao B; Dang Q; Chen Z; Zhou Q; Luo H; Yuan W; Sun Z
    Front Immunol; 2021; 12():674074. PubMed ID: 34858386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The roles of nausea and vomiting in COVID-19: did we miss something?
    Zhang T; Liu D; Tian D; Xia L
    J Microbiol Immunol Infect; 2021 Aug; 54(4):541-546. PubMed ID: 34435559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.
    Guo YR; Cao QD; Hong ZS; Tan YY; Chen SD; Jin HJ; Tan KS; Wang DY; Yan Y
    Mil Med Res; 2020 Mar; 7(1):11. PubMed ID: 32169119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of Gastrointestinal and Hepatic Manifestations of SARS-CoV-2 Infection in 892 Patients in Queens, NY.
    Ferm S; Fisher C; Pakala T; Tong M; Shah D; Schwarzbaum D; Cooley V; Hussain S; Kim SH
    Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2378-2379.e1. PubMed ID: 32497637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. It Ain't Over 'Til It's Over: SARS CoV-2 and Post-infectious Gastrointestinal Dysmotility.
    Coles MJ; Masood M; Crowley MM; Hudgi A; Okereke C; Klein J
    Dig Dis Sci; 2022 Dec; 67(12):5407-5415. PubMed ID: 35357608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome.
    Villapol S
    Transl Res; 2020 Dec; 226():57-69. PubMed ID: 32827705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver.
    Lei HY; Ding YH; Nie K; Dong YM; Xu JH; Yang ML; Liu MQ; Wei L; Nasser MI; Xu LY; Zhu P; Zhao MY
    Biomed Pharmacother; 2021 Jan; 133():111064. PubMed ID: 33378966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastrointestinal and Hepatic Manifestations of COVID-19: Evolving Recognition and Need for Increased Understanding in Vulnerable Populations.
    Garland V; Kumar AB; Borum ML
    J Natl Med Assoc; 2021 Apr; 113(2):142-146. PubMed ID: 32807512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 induces barrier damage and inflammatory responses in the human iPSC-derived intestinal epithelium.
    Yamada S; Noda T; Okabe K; Yanagida S; Nishida M; Kanda Y
    J Pharmacol Sci; 2022 Jul; 149(3):139-146. PubMed ID: 35641026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Covid-19 and the digestive system.
    Wong SH; Lui RN; Sung JJ
    J Gastroenterol Hepatol; 2020 May; 35(5):744-748. PubMed ID: 32215956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
    Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
    J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 induces gastrointestinal symptoms and affects patients' prognosis.
    Jin S; Lu X; Xu C
    J Int Med Res; 2022 Oct; 50(10):3000605221129543. PubMed ID: 36238995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.